UnitedHealth Group is partnering with Eli Lilly to test the efficacy of its COVID-19 monoclonal antibody treatment, bamlanivimab, for patients at high risk of adverse outcomes. Bamlanivimab has not ...
The FDA issued an emergency use authorization (EUA) for pemivibart (Pemgarda) as COVID-19 pre-exposure prophylaxis in immunocompromised individuals who are unlikely to mount a sufficient immune ...
A recent study co-authored by a Warren Alpert Medical School professor showed the effectiveness of convalescent plasma therapies for treating COVID-19 early in its disease course and preventing ...
HOUSTON, Texas (KTRK) -- A recent CDC survey estimated one in 13 American adults have long COVID, meaning they have symptoms three or more months after first contracting the virus. Long COVID can be ...
Merck & Co Inc <a href=" target="_blank">(MRK.N) has agreed to acquire drugmaker OncoImmune in a deal that will give it control of a drug that could help ease symptoms and reduce deaths in patients ...
Time to recovery ranged from 9 to 19 days. The Food and Drug Administration (FDA) has expanded the approval of Veklury ® (remdesivir) to include the treatment of COVID-19 in pediatric patients from ...
The shelf-life of Gohibic has been extended from 24 to 30 months, when stored at 2 to 8°C (36°F to 46°F) for certain lots. The Food and Drug Administration (FDA) has authorized an extension to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback